Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

Thomas Greither1 Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany

Kersten Fischer2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany

Gerit Theil2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany

Marios Marcou1 Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany;2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany

Hans-Juergen Holzhausen3 Department of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany

Katrin Weigelt4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]

Ginette Serrero5 A&G Pharmaceutical Inc., Columbia, Maryland, USA;6 Program in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA

David Hicks5 A&G Pharmaceutical Inc., Columbia, Maryland, USA

Binbin Yue5 A&G Pharmaceutical Inc., Columbia, Maryland, USA

Paolo Fornara2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany

Bernd Wullich4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]

Helge Taubert4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]Correspondence[email protected]

Sven Wach4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]

Verena Lieb4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]

show all

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

Articles from other publishers (12)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

Citations (12)

Articles from other publishers (12)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date